Pain News and Research

Latest Pain News and Research

Repro-Med Systems receives FDA marketing approval for new subcutaneous needle sets

Repro-Med Systems, Inc., announced today that it has received approval from the Food and Drug Administration to begin U.S. marketing of its new Subcutaneous Needle Sets which the company is promoting as the HIgh Flo RMS Subcutaneous Needle Sets.

1 Jun 2011

National survey finds gender and race affect self-reported health

A survey of nearly 4,000 Americans finds that obese women reported significantly worse health than obese men. Blacks who were overweight also reported better health than blacks in the normal or obese weight categories.

1 Jun 2011

As work changes, docs and nurses changing too

There are no national surveys that track doctors' political leanings, but as more doctors move from business owner to shift worker, their historic alliance with the Republican Party is weakening ... Doctors were once overwhelmingly male and usually owned their own practices. They generally favored lower taxes and regularly fought lawyers to restrict patient lawsuits.

1 Jun 2011

CrystalGenomics begins enrollment in CG100649 Phase 2b osteoarthritis study

CrystalGenomics, Inc. and CG Pharmaceuticals, Inc., a biopharmaceutical company with 3 clinical stage candidates, has announced that the first patient has been enrolled for a Phase 2b clinical study of CG100649, CrystalGenomics' clinical stage novel NSAID candidate, in patients with knee or hip osteoarthritis.

1 Jun 2011

Ampio commences new anti-inflammatory agent Phase 1B trial in osteoarthritis

Ampio Pharmaceuticals, Inc. announced today that it received ethics board approval for a Phase 1B clinical trial in Australia of its biologic anti-inflammatory agent, Ampion.

1 Jun 2011

Birth control pill safety issues raised

The U.S. Food and Drug Administration (FDA) has announced that it is looking at results from two studies that showed there is a higher risk of blood clots in women taking new birth control pills containing the compound drospirenone. Some brand names include Yaz, Yasmin, Beyaz, Ocella, Loryna, Gianvi, Safyral, Syeda and Zarah.

1 Jun 2011

Chronic fatigue syndrome and mouse virus – no association

An earlier study published in 2009 had claimed that a mouse virus was the cause of chronic fatigue syndrome. New evidence suggests that this assumption is wrong. According to latest evidence the earlier study findings were likely based on contaminated lab samples, US researchers said Tuesday.

1 Jun 2011

First Edition: May 31, 2011

Today's headlines include articles on the federal efforts to improve hospital quality, the politics of Medicare and the move by some GOP governors to set up health exchanges.

31 May 2011

Heptares, AstraZeneca partner to discover and develop new GPCR drug targets

AstraZeneca and Heptares Therapeutics today announced they have entered a four-year collaboration focused on the potential discovery and development of new medicines targeting G-protein coupled receptors.

31 May 2011

Koreans show positive attitude towards end-of-life care for cancer patients: Study

Attitudes toward end-of-life care for cancer patients vary, but most patients, family members, oncologists and members of the public are receptive to withdrawing futile life-sustaining treatments in people who are dying, found a Korean study in CMAJ.

31 May 2011

Canadian women more aware of ovarian cancer now, but misconceptions remain

Canadian women know more about ovarian cancer than they did six years ago, but misconceptions remain that could lead to late diagnosis of the country's most fatal gynecologic cancer - a disease that claims the lives of 70% of those diagnosed.

30 May 2011

HHS uses new devices to meet growing need of joint replacements among baby boomers

"The number of patients in their 50s coming into my office asking for joint replacement is higher than ever," says Dr. Steven B. Haas, a knee surgeon at Hospital for Special Surgery in New York City.

30 May 2011

People with unexplained symptoms can benefit from traditional acupuncture

Attending frequently with medically unexplained symptoms is distressing for both patient and doctor and effective treatment or management options are limited: one in five patients have symptoms that remain unexplained by conventional medicine.

30 May 2011

Positive data from Augurex's RA biomarker blood test, novel drug target presented at EULAR conference

Augurex Life Sciences Corp. today reported that in London at the European League Against Rheumatism Conference, leading arthritis researchers presented important data on Augurex's rheumatoid arthritis biomarker blood test and novel drug target.

30 May 2011

New positive Cimzia phase IIIb study data on rheumatoid arthritis presented at EULAR meeting

UCB today announced data which showed that the addition of Cimzia to current therapy was associated with a rapid and consistent clinical response in a diverse group of rheumatoid arthritis (RA) patients.

30 May 2011

Oceana Therapeutics receives FDA approval for Solesta injectable gel to treat fecal incontinence

The U.S. Food and Drug Administration today approved a sterile, injectable gel to treat fecal incontinence in patients for whom other therapies such as diet change, fiber therapy or anti-motility medications failed.

30 May 2011

Optimer receives FDA approval for Dificid tablets to treat C. difficile-associated diarrhea

The U.S. Food and Drug Administration today approved Dificid tablets for the treatment of Clostridium difficile-associated diarrhea.

30 May 2011

Efficacy of Abbott cholesterol drug in question

A latest study has found that using medication to raise good cholesterol while lowering the bad does NOT translate into fewer adverse cardiovascular events like heart attacks and strokes. The study was revealed Thursday by the National Institutes of Health and it found that high dosages of Abbott Laboratories' Niaspan failed to prevent heart attacks and boosted the likelihood of a stroke when combined with the popular generic cholesterol pill Simvastatin, also known under the brand name Zocor.

29 May 2011

First Medicare Meaningful Use incentive dollars issued to physicians using athenahealth EHR

athenahealth, Inc., the leading provider of cloud-based practice management, electronic health record (EHR), and patient communication services to medical groups, today announced that the first Medicare Meaningful Use incentive payment dollars have been issued to its physician clients using athenaClinicals®, the company's EHR offering.

27 May 2011

Longer looks: Stem cells, vaccinating against addictive drugs, the GOP's budget hatchet man

Krista and Tatiana are not like most other sets of twins. They are connected at their heads, where their skulls merge under a mass of shaggy brown bangs. The girls run and play and go down their backyard slide, but whatever they do, they do together, their heads forever inclined toward each other's, their neck muscles strong and sinuous from a never-ending workout. Twins joined at the head — the medical term is craniopagus — are extremely rare.

27 May 2011

Pain News and Research

Latest Pain News and Research

Repro-Med Systems receives FDA marketing approval for new subcutaneous needle sets

National survey finds gender and race affect self-reported health

As work changes, docs and nurses changing too

CrystalGenomics begins enrollment in CG100649 Phase 2b osteoarthritis study

Ampio commences new anti-inflammatory agent Phase 1B trial in osteoarthritis

Birth control pill safety issues raised

Chronic fatigue syndrome and mouse virus – no association

First Edition: May 31, 2011

Heptares, AstraZeneca partner to discover and develop new GPCR drug targets

Koreans show positive attitude towards end-of-life care for cancer patients: Study

Canadian women more aware of ovarian cancer now, but misconceptions remain

HHS uses new devices to meet growing need of joint replacements among baby boomers

People with unexplained symptoms can benefit from traditional acupuncture

Positive data from Augurex's RA biomarker blood test, novel drug target presented at EULAR conference

New positive Cimzia phase IIIb study data on rheumatoid arthritis presented at EULAR meeting

Oceana Therapeutics receives FDA approval for Solesta injectable gel to treat fecal incontinence

Optimer receives FDA approval for Dificid tablets to treat C. difficile-associated diarrhea

Efficacy of Abbott cholesterol drug in question

First Medicare Meaningful Use incentive dollars issued to physicians using athenahealth EHR

Longer looks: Stem cells, vaccinating against addictive drugs, the GOP's budget hatchet man

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Pain News and Research

Latest Pain News and Research

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in